---
schema_version: "secwatch.filing_event.v1"
accession: "0001531048-24-000009"
form_type: "8-K/A"
ticker: null
cik: "0001531048"
company_name: "Inari Medical, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T13:25:48.163225+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Inari Medical closes LimFlow acquisition; LimFlow reports €20.3M net loss on €938K revenue for 9 months ended Sep 2023

## Summary
- Acquired LimFlow, developer of TADV system for no-option CLTI patients; deal value undisclosed, announced Oct 2023.
- LimFlow's audited financials: €20.3M net loss on €938K revenue (nine months through Sep 30, 2023); €18.8M loss on €252K revenue (FY 2022).
- As of Sep 30, 2023, LimFlow had €3.1M cash, €1.5M total debt, and accumulated deficit of €101.3M.
- Inari filed pro forma combined financials reflecting the acquisition; no additional guidance on future earnings impact provided.

## SEC filing metadata
- accession: 0001531048-24-000009
- form_type: 8-K/A
- cik: 0001531048
- company_name: Inari Medical, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 9.01, 2.01, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000009/0001531048-24-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000009/nari-20231115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001531048-24-000009
- JSON: https://secwatch.observer/filing/0001531048-24-000009.json
- Plain text: https://secwatch.observer/filing/0001531048-24-000009.txt

## Key facts
- M&A Transactions
  Inari Medical, Inc. completed an acquisition involving LimFlow S.A. (closed 2023-11-15).
  - Action: acquisition
  - Counterparty: LimFlow S.A.
  - Closing: 2023-11-15
  source text: announced that it closed its acquisition (the “Acquisition”) of LimFlow S.A.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000009/0001531048-24-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.